Rory B Riggs is Director of Royalty Pharma plc. Currently has a direct ownership of 320,099 shares of RPRX, which is worth approximately $10.7 Million. The most recent transaction as insider was on Nov 16, 2021, when has been sold 66,012 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 320K
0% 3M change
0% 12M change
Total Value Held $10.7 Million

RORY B RIGGS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2021
BUY
Other acquisition or disposition
-
66,012 Added 8.65%
697,398 Class A Ordinary Shares
Sep 29 2021
SELL
Open market or private sale
$899,652 $36.5 p/Share
24,648 Reduced 3.85%
615,112 Class A Ordinary Shares
Sep 29 2021
BUY
Other acquisition or disposition
-
16,274 Added 2.51%
631,386 Class A Ordinary Shares
Sep 28 2021
SELL
Open market or private sale
$1,470,000 $36.75 p/Share
40,000 Reduced 5.88%
639,760 Class A Ordinary Shares
May 07 2021
BUY
Conversion of derivative security
-
679,760 Added 50.0%
679,760 Class A Ordinary Shares
Oct 20 2020
SELL
Open market or private sale
$19,454,400 $42.0 p/Share
463,200 Reduced 100.0%
0 Class A Ordinary Shares
Oct 20 2020
BUY
Conversion of derivative security
-
463,200 Added 50.0%
463,200 Class A Ordinary Shares
Dec 12 2002
SELL
Open market or private sale
$1,679,619 $41.98 p/Share
40,010 Reduced 29.26%
96,712 Class A Ordinary Shares

Also insider at

ITCI
Intra-Cellular Therapies, Inc. Healthcare
FGEN
FIBROGEN INC Healthcare
CLXT
Calyxt, Inc. Consumer Defensive
RBR

Rory B Riggs

Director
New York, NY

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if
Any

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Royalty Pharma plc

Track Activities on RPRX